NO992532D0 - Heptapeptid oksytocinanaloger - Google Patents

Heptapeptid oksytocinanaloger

Info

Publication number: NO992532D0
Authority: NO; Norway
Prior art keywords: oxytocin analogs; heptapeptide; heptapeptide oxytocin; analogs; oxytocin
Prior art date: 1996-11-26

Application number

NO992532A

Other languages

English (en)

Other versions

NO321380B1 (no

NO992532L (no

Inventor

Per Melin

Anders Nilsson

Jerzy Trojnar

Carl-Johan Aurell

Pierre Riviere

Robert Haig

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-26

Filing date

1999-05-26

Publication date

1999-05-26

1999-05-26 Application filed by Ferring Bv filed Critical Ferring Bv

1999-05-26 Publication of NO992532D0 publication Critical patent/NO992532D0/no

1999-05-26 Publication of NO992532L publication Critical patent/NO992532L/no

2006-05-02 Publication of NO321380B1 publication Critical patent/NO321380B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Neurology (AREA)
Biochemistry (AREA)
Pregnancy & Childbirth (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO19992532A 1996-11-26 1999-05-26 Heptapeptid analog med oksytocinantagonistaktivitet, fremgangsmate ved fremstilling derav samt anvendelse derav til fremstilling av medikamenter. NO321380B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9604341A SE9604341D0 (sv)	1996-11-26	1996-11-26	Hepta-peptide oxytocin analogue
PCT/SE1997/001968 WO1998023636A1 (en)	1996-11-26	1997-11-21	Heptapeptide oxytocin analogues

Publications (3)

Publication Number	Publication Date
NO992532D0 true NO992532D0 (no)	1999-05-26
NO992532L NO992532L (no)	1999-05-26
NO321380B1 NO321380B1 (no)	2006-05-02

Family

ID=20404757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19992532A NO321380B1 (no)	1996-11-26	1999-05-26	Heptapeptid analog med oksytocinantagonistaktivitet, fremgangsmate ved fremstilling derav samt anvendelse derav til fremstilling av medikamenter.

Country Status (34)

Country	Link
US (1)	US6143722A (no)
EP (1)	EP0938496B1 (no)
JP (1)	JP3405460B2 (no)
KR (1)	KR100463132B1 (no)
CN (1)	CN1129606C (no)
AR (1)	AR008531A1 (no)
AT (1)	ATE242264T1 (no)
AU (1)	AU713424B2 (no)
BR (1)	BR9713366B1 (no)
CA (1)	CA2272990C (no)
CZ (1)	CZ299532B6 (no)
DE (1)	DE69722651T2 (no)
DK (1)	DK0938496T3 (no)
EE (1)	EE03832B1 (no)
ES (1)	ES2203823T3 (no)
HR (1)	HRP970630B1 (no)
HU (1)	HU228568B1 (no)
IL (1)	IL129519A (no)
LT (1)	LT4650B (no)
LV (1)	LV12350B (no)
MY (1)	MY125555A (no)
NO (1)	NO321380B1 (no)
NZ (1)	NZ336445A (no)
PL (1)	PL189292B1 (no)
PT (1)	PT938496E (no)
RO (1)	RO120772B1 (no)
RU (1)	RU2180668C2 (no)
SE (1)	SE9604341D0 (no)
SI (1)	SI20026B (no)
SK (1)	SK283800B6 (no)
TR (1)	TR199901028T2 (no)
UA (1)	UA54459C2 (no)
WO (1)	WO1998023636A1 (no)
ZA (1)	ZA9710518B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2181297C2 (ru) *	2000-06-20	2002-04-20	Эпштейн Олег Ильич	Способ лечения патологического синдрома и лекарственное средство
US6476072B1 (en) *	2000-11-21	2002-11-05	Arthur Vanmoor	Method of treating menstrual pain by enhancing the effectiveness of the human immune system
ATE346084T1 (de) *	2002-02-27	2006-12-15	Ferring Bv	Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
WO2003093816A2 (en) *	2002-05-02	2003-11-13	Bayer Healtchare Ag	Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
UA76639C2 (uk) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
SI1500390T1 (sl) *	2003-07-25	2006-02-28	Ferring Bv	Farmacevtski dezmopresinski sestavek kot trdna dozirna oblika in postopek za njegovo pripravo
PT1530967E (pt) *	2003-11-13	2006-09-29	Ferring Bv	Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
EP1555029A1 (en)	2004-01-19	2005-07-20	Ferring B.V.	Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
US20060171909A1 (en) *	2005-02-03	2006-08-03	The Procter & Gamble Company	Cosmetic compositions comprising colorants with low free dye
SE0600482L (sv) *	2006-03-02	2006-11-14	Ferring Int Ct Sa	Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
KR101522747B1 (ko)	2007-08-06	2015-05-26	알레간 인코포레이티드	데스모프레신 약물 전달을 위한 방법 및 장치
MX2010010743A (es) *	2008-03-31	2010-11-04	Ferring Bv	Analogos de oxitocina.
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
HUE041370T2 (hu)	2008-05-21	2019-05-28	Ferring Bv	Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
TWI463990B (zh) *	2009-09-21	2014-12-11	Ferring Bv	催產素受體促進劑
MX2013000543A (es)	2010-07-15	2013-10-28	Oleg Iliich Epshtein	Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo.
JO3400B1 (ar) *	2010-09-30	2019-10-20	Ferring Bv	مركب صيدلاني من كاربيتوسين
EP2684888B1 (en)	2011-03-09	2019-05-15	Jitsubo Co., Ltd.	Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
CN102875650B (zh) *	2012-09-26	2014-06-11	深圳翰宇药业股份有限公司	巴卢西班的制备方法
US9365615B2 (en)	2013-09-09	2016-06-14	Jitsubo Co., Ltd.	Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
EP3501533B1 (en) *	2014-12-22	2025-07-09	Ferring B.V.	Obe001 for use in the treatment in implantation and pregnancy in women undergoing assisted reproductive technologies
US9925233B2 (en)	2015-01-30	2018-03-27	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en)	2015-01-30	2016-06-28	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en)	2015-01-30	2017-08-29	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en)	2015-01-30	2017-06-27	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en)	2015-01-30	2018-04-10	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en)	2015-01-30	2017-09-05	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
JP2018535946A (ja)	2015-10-06	2018-12-06	フェリング・ベー・フェー	バルシバン及びその中間体を作製する新規の方法
WO2017118639A1 (en)	2016-01-04	2017-07-13	ObsEva S.A.	Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
US20190247361A1 (en)	2016-07-21	2019-08-15	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
EP4025207A1 (en)	2019-09-03	2022-07-13	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CA3167121A1 (en)	2020-02-10	2021-08-19	ObsEva S.A.	Biomarkers for oxytocin receptor antagonist therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ279654B6 (cs) *	1987-12-21	1995-05-17	Sandoz Ag	Způsob výroby cyklosporinu A
US5373089A (en) *	1988-09-02	1994-12-13	Northwestern University	Oxytocin antagonist
CA2036973A1 (en) *	1990-02-27	1991-08-28	Mark G. Bock	Cyclic hexapeptide oxytocin antagonists
SE9002384D0 (sv) *	1990-07-09	1990-07-09	Ferring Ab	Derivat av baklobshormoner
DE4022247A1 (de) *	1990-07-12	1992-01-16	Hoechst Ag	Verfahren zur extraktiven abtrennung von 2-alkylthio-5-phenylpyrimidinen aus ihren reaktionsgemischen
SE501678C2 (sv) *	1993-07-13	1995-04-10	Ferring Bv	Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE523819C2 (sv)	1994-01-27	2004-05-18	Per-Ingvar Nilsson	Accelerationsmunstycke samt metod för dess användning
SE9400918L (sv)	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
SE503085C2 (sv)	1995-01-25	1996-03-25	Valeo Engine Cooling Ab	Värmeväxlartank med ändstycken, förfarande för framställning av en sådan tank, samt värmeväxlare försedd med en sådan

1996
- 1996-11-26 SE SE9604341A patent/SE9604341D0/xx unknown
1997
- 1997-11-21 DE DE69722651T patent/DE69722651T2/de not_active Expired - Lifetime
- 1997-11-21 KR KR10-1999-7004449A patent/KR100463132B1/ko not_active Expired - Lifetime
- 1997-11-21 PT PT97946210T patent/PT938496E/pt unknown
- 1997-11-21 UA UA99042410A patent/UA54459C2/uk unknown
- 1997-11-21 EP EP97946210A patent/EP0938496B1/en not_active Expired - Lifetime
- 1997-11-21 ZA ZA9710518A patent/ZA9710518B/xx unknown
- 1997-11-21 NZ NZ336445A patent/NZ336445A/en not_active IP Right Cessation
- 1997-11-21 PL PL97333876A patent/PL189292B1/pl unknown
- 1997-11-21 RO RO99-00593A patent/RO120772B1/ro unknown
- 1997-11-21 TR TR1999/01028T patent/TR199901028T2/xx unknown
- 1997-11-21 ES ES97946210T patent/ES2203823T3/es not_active Expired - Lifetime
- 1997-11-21 BR BRPI9713366-3A patent/BR9713366B1/pt not_active IP Right Cessation
- 1997-11-21 US US09/308,912 patent/US6143722A/en not_active Expired - Lifetime
- 1997-11-21 IL IL12951997A patent/IL129519A/en not_active IP Right Cessation
- 1997-11-21 SI SI9720076A patent/SI20026B/sl unknown
- 1997-11-21 HU HU0000577A patent/HU228568B1/hu unknown
- 1997-11-21 CZ CZ0183299A patent/CZ299532B6/cs not_active IP Right Cessation
- 1997-11-21 AT AT97946210T patent/ATE242264T1/de active
- 1997-11-21 WO PCT/SE1997/001968 patent/WO1998023636A1/en not_active Ceased
- 1997-11-21 DK DK97946210T patent/DK0938496T3/da active
- 1997-11-21 AU AU51429/98A patent/AU713424B2/en not_active Expired
- 1997-11-21 SK SK704-99A patent/SK283800B6/sk not_active IP Right Cessation
- 1997-11-21 HR HR970630A patent/HRP970630B1/xx not_active IP Right Cessation
- 1997-11-21 EE EEP199900210A patent/EE03832B1/xx unknown
- 1997-11-21 CN CN97180014A patent/CN1129606C/zh not_active Expired - Fee Related
- 1997-11-21 JP JP52460298A patent/JP3405460B2/ja not_active Expired - Lifetime
- 1997-11-21 CA CA002272990A patent/CA2272990C/en not_active Expired - Lifetime
- 1997-11-21 RU RU99113364/04A patent/RU2180668C2/ru active
- 1997-11-25 MY MYPI97005691A patent/MY125555A/en unknown
- 1997-11-26 AR ARP970105543A patent/AR008531A1/es active IP Right Grant
1999
- 1999-04-30 LV LVP-99-77A patent/LV12350B/en unknown
- 1999-05-11 LT LT99-052A patent/LT4650B/lt not_active IP Right Cessation
- 1999-05-26 NO NO19992532A patent/NO321380B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0938496T3 (da)	2003-10-06
EP0938496B1 (en)	2003-06-04
IL129519A (en)	2004-09-27
AU5142998A (en)	1998-06-22
RO120772B1 (ro)	2006-07-28
LV12350B (en)	1999-11-20
SE9604341D0 (sv)	1996-11-26
KR100463132B1 (ko)	2004-12-23
LT99052A (en)	2000-01-25
ZA9710518B (en)	1998-06-10
DE69722651D1 (en)	2003-07-10
EE03832B1 (et)	2002-08-15
LT4650B (lt)	2000-04-25
PL189292B1 (pl)	2005-07-29
EE9900210A (et)	1999-12-15
CA2272990C (en)	2002-11-19
SI20026A (sl)	2000-02-29
HK1022481A1 (en)	2000-08-11
AR008531A1 (es)	2000-01-19
EP0938496A1 (en)	1999-09-01
SK283800B6 (sk)	2004-02-03
TR199901028T2 (xx)	1999-07-21
JP3405460B2 (ja)	2003-05-12
ATE242264T1 (de)	2003-06-15
UA54459C2 (uk)	2003-03-17
WO1998023636A1 (en)	1998-06-04
ES2203823T3 (es)	2004-04-16
HRP970630B1 (en)	2002-04-30
NZ336445A (en)	2000-06-23
NO321380B1 (no)	2006-05-02
KR20000069045A (ko)	2000-11-25
CN1238781A (zh)	1999-12-15
IL129519A0 (en)	2000-02-29
JP2000507617A (ja)	2000-06-20
CZ299532B6 (cs)	2008-08-27
SK70499A3 (en)	2000-10-09
BR9713366A (pt)	2000-01-25
CZ183299A3 (cs)	2000-05-17
DE69722651T2 (de)	2004-04-08
PT938496E (pt)	2003-10-31
HUP0000577A2 (hu)	2000-11-28
HU228568B1 (en)	2013-04-29
CN1129606C (zh)	2003-12-03
BR9713366B1 (pt)	2010-05-18
LV12350A (lv)	1999-09-20
CA2272990A1 (en)	1998-06-04
HUP0000577A3 (en)	2001-02-28
US6143722A (en)	2000-11-07
HRP970630A2 (en)	1998-10-31
AU713424B2 (en)	1999-12-02
SI20026B (sl)	2000-06-30
RU2180668C2 (ru)	2002-03-20
NO992532L (no)	1999-05-26
MY125555A (en)	2006-08-30

Publication	Publication Date	Title
DK0938496T3 (da)	2003-10-06	Heptapeptidoxytocinanaloger
FI965225A7 (fi)	1997-02-26	Uusia peptidejä
NO983069D0 (no)	1998-07-02	Inhalasjonsanordning
DK1042359T3 (da)	2005-11-28	k-Opioidreceptorpeptider
DE69625739D1 (de)	2003-02-20	Schlauchaufbau enthaltend Fluorterpolymere
DE59707564D1 (de)	2002-07-25	Fungizide mischung
FI961350A7 (fi)	1996-03-25	Hapteenimerkityt peptidit
FI102731B1 (fi)	1999-02-15	Näyteputki
FR2747926B1 (fr)	2001-05-11	Inhalateurs ameliores
DE59806407D1 (de)	2003-01-09	Drucktaster
NO985680L (no)	1999-02-04	Peptidderivater
EP0996458A4 (en)	2001-05-02	SANDRAMYCIN ANALOG
EP0985372A4 (en)	2004-06-02	VACUUM CLEANER
DE19581877T1 (de)	1997-12-11	Verbesserter Kreiselbrecher
NO983849L (no)	1998-10-21	Peptidderivater
FI970168L (fi)	1997-01-15	Peptidejä
FI963194A7 (fi)	1996-09-23	Syklinen tulehduksenvastainen heptapeptidi
FI964363L (fi)	1996-12-23	Peptidejä
DE59801799D1 (de)	2001-11-22	Reinigungsgerät
DE69819097D1 (de)	2003-11-27	Drucktaster
DE59706870D1 (de)	2002-05-08	Fungizide mischung
DE59803807D1 (de)	2002-05-23	Reinigungsgerät
DK1137667T3 (da)	2005-02-14	GLP-1-analoger
DE69715327D1 (de)	2002-10-17	Reinigungsgerät
FI950211L (fi)	1995-07-20	Huokosia muodostavia peptidejä Geolycosa riograndesta

Legal Events

Date	Code	Title	Description
2017-12-11	MK1K	Patent expired